New Jersey: The Life Sciences Commercialization Hub
December 10, 2018 @ 10:30 am - 2:00 pm| $85
Registration: 10:30 AM
Panel Discussion: 11:00 AM—12:15 PM
Lunch and Keynote: 12:30 PM—2:00 PM
Chairman and CEO of Amicus Therapeutics
John Crowley presently serves as the Chairman and CEO of Amicus of Cranbury, NJ. John has overseen growth of Amicus from four employees to over 400 with global operations in more than 27 countries and offices in the United States and throughout Japan and Europe and a market valuation of more than $3 Billion. Amicus is recognized as a leading biotechnology company focused on developing treatments for rare and devastating diseases.
New Jersey’s Climate for Commercialization
Dean J. Paranicas
President and Chief Executive Officer
HealthCare Institute of New Jersey
Prior to joining HINJ, Dean Paranicas was Vice President, Corporate Secretary and Public Policy for BD. Starting at BD in 1981, he previously served in various legal roles, and also as Director, Corporate Development and Strategic Investments, as Director, Investor Relations, and as Vice President, Investor Relations and Public Affairs.
For more information, contact Beth Kujan at firstname.lastname@example.org or call
(973) 539-3882 x238